Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Pharma testing

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Aripiprazole Manufacturers in India Suppliers Aripiprazole Dossage Exporters Distributors Aripiprazole api active pharmaceuticals ingredients Aripiprazole manufacturers Side Effects bulk drugs raw material Dossage Aripiprazole companies Side Effects Dossage Importers Aripiprazole Dossage Aripiprazole Exporters Aripiprazole exporters Dossage FDA Dossage Aripiprazole Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Aripiprazole manufacturing pharmaceutical drugs pharmaceutical intermediates Aripiprazole pharmaceutical chemicals pharmaceutical raw materials Aripiprazole active pharmaceutical ingredients Aripiprazole committee active pharmaceutical ingredients manufacturer Aripiprazole Active Pharmaceutical Ingredients manufacturer Aripiprazole exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Aripiprazole, Aripiprazole manufacturer India, Aripiprazole product, Aripiprazole products, Api preparation, Certificate of Analysis API manufacturer product, Aripiprazole anti ulcer product, Certificate of Origin COA Aripiprazole COS Aripiprazole, pharmaceutical generic, pharmaceutical drug, medical, Aripiprazole pharma healthcare, pharma patents, contract MSDS manufacturing Trader Aripiprazole pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Aripiprazole expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Aripiprazole DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Aripiprazole ingredients, api, HIV Aripiprazole, tablets, capsules, syrup & protein Aripiprazole powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Aripiprazole gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Aripiprazole WHO, UKMHRA Approval

 
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
drug information  
Chemical data





 

 

 

 









 

 

 
HOME >> Pharmaceuticals API List 1 >> Aripiprazole >> Dosage

Aripiprazole  CAS number 129722-12-9
DOASAGE
Cas No. 129722-12-9

Aripiprazole usually is taken once per day. The starting amount usual is magnesium 10 or 15 once daily. The amount can be increased with the hour to carry out the desired effect. Aripiprazole can be taken with or without food.

What should you do if you miss a dose?

If you miss an amount, and if you remember the same day, then you if the motionless catch it that day. If you remember the next day, jump the missed amount then, and take your regular proportioning, do not double upwards on your amount.                      

Symptoms of overdose include nausea, weakness, diarrhea, somnolence, and vomiting. Treatment is supportive; an ECG should be obtained and monitored if abnormalities are present. Due to the high degree of protein binding, hemodialysis is unlikely to be effective in removing aripiprazole.

Children 10 to 17 yr of age

PO Start with 2 mg/day, then titrate to 5 mg/day after 2 days, and to a target dose of 10 mg after 2 additional days. Subsequent dose increases should be in 5 mg/day increments. 30 mg/day was not shown to be more efficacious than 10 mg/day.

General Advice

  • May be given orally without regard to meals.
  • Parenteral administration is intended for IM use only; inject slowly, deep into muscle mass. Do not give IV or subcutaneously.
  • Oral solution may be substituted for tablets on a mg-per-mg basis up to a 25 mg dose. Patients receiving 30 mg tablets should receive 25 mg of the solution.
  • Dosing for the orally disintegrating tablet is the same as the oral tablet.
  • IM injection has not been evaluated in children.

Information Associated with Product :  

Dosage >>
Uses
Side Effects
Interactions


                       
PDF DOWNLOAD      WORD DOCUMENT
 
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  




Taj pharmaceuticals API Logo

Aripiprazole

More Api at Taj Pharmaceuticals Ltd.

Alfuzosin

Oseltamivir Phosphate

 Amlodipine Besylate

Aripiprazole

Atorvastatin Calcium

Candesartan Cilaxetil

Cefdinir

Cetirizine Dihydrochloride

Ciprofloxacin HCl

Dextromethorphan Base

Diltiazem HCl

Domperidone Base

Domperidone Maleate

Doxazosin Mesylate

 Duloxetine HCl

Dutasteride

Enalapril Maleate

Esomeprazole Magnesium

Famotidine

Fexofenadine HCl

Fluconazole

Fluoxetine HCl

Galantamine HBr

Ibuprofen

Caffeine

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.